On Thursday, Shares of Microsoft Corporation (NASDAQ:MSFT), lost -0.36% to $46.44.
AVI-SPL, the world’s leading AV systems integrator, is happy to declare its participation in the Microsoft Surface Hub commercial sales channel. AVI-SPL is a Microsoft authorized reseller with coverage in the U.S., Canada and the U.K. AVI-SPL is poised to bring its historical strength as a global leader in AV integration to partner with Microsoft and will be represented in Microsoft’s InfoComm booth in Orlando next week June 17-19 . (1079)
Accessible for ordering starting July 1, 2015 , the Surface Hub “unlocks the power of the group” with features like an interactive whiteboard, multi-device partnership and Skype for Business integration. Surface Hub will harness the power of Windows 10, Skype for Business, Office, OneNote and Universal Windows apps to deliver a new kind of productivity experience optimized for groups. The unique experience is designed to be just as engaging for people working together in the same room as for those connecting remotely.
“Improving connections between teams has been AVI-SPL’s focus since our founding in 1979, and Surface Hub is a noteworthy solution that will transform the way we communicate and collaborate,” said John Zettel , AVI-SPL CEO. “We’re excited to partner with Microsoft to deliver these collaborative tools to our customers.”
Microsoft Corporation develops, licenses, markets, and supports software, services, and devices worldwide. The company’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system.
Shares of Boston Scientific Corporation (NYSE:BSX), inclined 0.39% to $17.81, during its last trading session.
Boston Scientific Corporation, presented new data demonstrating that the Precision Spectra™ Spinal Cord Stimulator (SCS) System offered 1.5 times better overall pain relief and 2 times better low back pain relief than the previous generation Precision Plus™ SCS system. The improved outcomes with the Precision Spectra System were achieved in conjunction with the use of the proprietary Illumina™ 3D neural targeting software, designed to target pain with point-and-click simplicity. Results from the LUMINA cohort of the Precision Spectra System observational study were presented this week at the International Neuromodulation Society 12th World Congress in Montreal, Canada.
The LUMINA cohort comprises three patient groups: 213 successive patients treated with the Precision Spectra System for up to 24 months post-implant; 130 successive patients treated with the previous generation system, Precision Plus™, in a comparative evaluation with the Precision Spectra System; and 25 successive patients treated with the Precision Spectra System and the new CoverEdge 32 Surgical Leads for up to 6 months post-implant.
“The results are exciting because we looked at successive patients – some with only low back pain – in a real-world setting,” said Julie Pilitsis, M.D., Ph.D., associate professor, Albany Medical College and one of the lead investigators for this study. “This is strong clinical evidence of the effectiveness of the Precision Spectra System in treating the types of challenging chronic pain patients that physicians see every day.”
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
Finally, Altera Corp. (NASDAQ:ALTR), ended its last trade with 0.09% gain, and closed at $51.59.
Altera Corporation, revealed architectural and product details of its Stratix® 10 FPGAs and SoCs, the next generation of high-end programmable logic devices delivering breakthrough levels of performance, integration, density and security.
Stratix 10 FPGAs and SoCs leverage Altera’s revolutionary HyperFlex™ FPGA fabric architecture built on the Intel® 14 nm Tri-Gate process to provide 2X higher core performance over previous generation FPGAs. Combining the industry’s highest performance, highest density FPGA with advanced embedded processing capabilities, GPU-class floating point computation performance and heterogeneous 3D SiP integration, enables Altera customers to uniquely address design challenges in the next generation of communications, data center, IoT infrastructure, military and high-performance computing systems.
“The capabilities that we offer in Stratix 10 FPGAs and SoCs are truly unmatched in the industry,” said Danny Biran, senior vice president of marketing at Altera. “Stratix 10 FPGAs and SoCs will enable our customers to design their systems and innovate in ways that were formerly not possible in an FPGA.”
HyperFlex Architecture “Registers Everywhere” Approach.
Altera Corporation, a semiconductor company, designs and sells programmable logic devices (PLDs), HardCopy application-specific integrated circuit (ASIC) devices, power system-on-chip devices (PowerSoCs), pre-defined design building blocks, and associated development tools.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
